Explore › Finding
Finding null
In patients with NAFLD and diabetes, sulfonylureas alone and in combination with other oral diabetes medications did not significantly reduce the risk of hepatocellular carcinoma.
Effect sizeHR 0.89
CI95% CI 0.73-1.08
Comparatorno diabetes medication
Effect summarynull; HR 0.89; CI: 95% CI 0.73-1.08

Connected entities

Interventions
Hypoglycemic Sulfonylureas
Conditions
Non-alcoholic Fatty Liver Disease
Outcomes
Hepatocellular carcinoma
Populations
Type 2 Diabetes Patients

Source

PMC9107529
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
Read on PMC → · View in graph →